# Alatawi et al.: Microbiota and anti-TNF-α response in IBD patients

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013;504(7480):451-5. https://doi.org/10.1038/nature12726

[32] Ahuja V. Inventory of a reservoir: Friends And foes. Indian J Med Res 2015;142(1):4-6.

[30] Doron S, Snydman DR. Risk and safety of probiotics. Clin Infect Dis 2015;60 Suppl 2:S129-34.

[31] Goldstein EJ, Citron DM, Peraino VA, Cross SA. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. J Clin Microbiol 2003;41(6):2752-4.

[33] Erickson AR, Cantarel BL, Lamendella R, Darzi Y, Mongodin EF, Pan C, et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn’s disease. PLoS One 2012;7(11):e49138. https://doi.org/10.1371/journal.pone.0049138

# Related articles published in BJBMS

1. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches

Dikhnah Alshehri et al., BJBMS, 2020
2. Reconstruction of intestinal microecology of Type 2 diabetes by fecal microbiota transplantation: Why and how

Kaijian Hou et al., BJBMS

Bosn J Basic Med Sci. 2022;22(3):412-426

www.bjbms.org